Weber Medicine & Clinical Case Reports

May 2019, Vol. 7 (1), ISSN:2449-1624

© Author(s) 2019. This work is distributed under the Creative Commons Attribution 3.0 License.

Research Article

Botulinum Toxin Type A in the Treatment of Hyperhidrosis: Case Study

Caroliny Scarlett Pardo Muraro1, Sabrina de Almeida Marques1, Ana Beatriz Carollo Rocha-Lima1, Denise Aparecida Gonçalves de Oliveira1, Érika Simone Lopes1, Cristina Tischer Ranalli Aparecido1, Cláudia de Moura1  & Veronica Cristina Gomes Soares1

1Universidade Paulista - UNIP, Campus Jundiaí, Instituto de Ciências da Saúde. Avenida Armando Giassetti, 577 - Vila Hortolândia - Trevo Itu/Itatiba - Jundiaí-SP/Brazil, CEP 13214-525.

Accepted 1st May, 2019; Available Online 2nd May, 2019.


Hyperhidrosis is a pathology that affects 1% of the population and is characterized by immoderate sweat that leads to psychological problems and hinders social interaction. The purpose of this study was to analyze the impact of hyperhidrosis patient's life quality before and after treatment with botulinum toxin type A. The procedure was performed in the city of Jundiaí-SP/Brazil, at Day Hospital Nova Plástica Clinic, where a qualified professional, medical plastic surgeon, has performed intradermal application in a patient suffering from hyperhidrosis in the palmar region. A questionnaire adapted from Baroncello et al. (2014), containing closed questions assessing the patient's life quality before and after treatment. The questions were pointed out on a score from 0 to 100, and closer to 100, it means better life quality. The questionnaire was applied to the patient before the procedure and thirty days after the procedure, and with that the impacts caused on the life quality of the volunteer were evaluated. The questionnaire was applied in a male patient, 22 years old. The result before application of botulinum toxin was 28 points and after the application, 90 points. In addition to temporary adverse effects, no compensatory hyperhidrosis was reported, which resulted in improved life quality and patient satisfaction. Therefore, the therapeutic use of botulinum toxin type A for primary hyperhidrosis was shown to be safe, minimized sweating and positively impacted patient's life quality , thus corroborating with the related literature.

[ View Abstract ]                        [ Full Text: PDF ]

Information for Authors
Author Guidelines

Manuscript Submission

Author FAQ

Copyright Policy

Publishing Ethics

Article Processing Fee

Join Us

As an Editor/Reviewer